Armata Pharmaceuticals

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$966
$1,528
$1,225
Gross Profit
-315
649
1,235
1,004
EBITDA
-11,599
-9,911
-9,286
-25,901
EBIT
-11,914
-10,228
-9,579
-26,122
Net Income
8,986
-25,021
-19,847
-31,161
Net Change In Cash
0
966
1,528
1,225
Free Cash Flow
-11,543
-10,834
-10,506
-13,199
Cash
26,405
37,860
13,523
23,958
Basic Shares
58,246
36,124
36,100
36,086

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$4,529
$5,508
$4,474
$823
Gross Profit
-29,241
4,616
-15,541
-13,621
EBITDA
-39,918
-36,054
-22,648
-20,439
EBIT
-40,890
-36,946
-23,817
-21,553
Net Income
-69,045
-36,888
-23,219
-22,815
Net Change In Cash
4,529
5,508
4,474
823
Cost of Revenue
9,324
639
4,116
Free Cash Flow
-55,567
-34,692
-24,879
-19,094
Cash
13,523
14,852
10,288
9,649
Basic Shares
36,075
34,294
24,104
16,415

Earnings Calls

Quarter EPS
2024-06-30
$0.25
2024-03-31
-$0.69
2023-12-31
-$0.55
2023-09-30
-$0.75